UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from ____________ to ____________ Commission File Number 001-36288 Akari Therapeutics, Plc (Exact name of registrant as specified in its charter) England and Wales 98-1034922 (State or other jurisdiction of incorporation or organization) 22 Boston Wharf Road, FL 7 Boston, Massachusetts 02210 (I.R.S. Employer Identification No.) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECUR ...